Stock Taper 
VESTAL POINT CAPITAL, LP
Latest 13F filing data - Q2 2026
Holdings
(Top positions)| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
 BioCryst Pharmaceuticals, Inc. | BCRX | 8.3M | $83M |
 Nurix Therapeutics, Inc. | NRIX | 8.05M | $195.29M |
 BioMarin Pharmaceutical Inc. | BMRN | 6.03M | $344.75M |
 Myriad Genetics, Inc. | MYGN | 5.74M | $32.75M |
 Bicara Therapeutics Inc. Common Stock | BCAX | 5.25M | $155.87M |
 Monte Rosa Therapeutics, Inc. | GLUE | 4.6M | $111.32M |
 Enliven Therapeutics, Inc. | ELVN | 4M | $203M |
 Dyne Therapeutics, Inc. | DYN | 3.38M | $74.96M |
 Trevi Therapeutics, Inc. | TRVI | 3.1M | $57.81M |
 Abivax S.A. | ABVX | 2.35M | $313.09M |
 Solid Biosciences Inc. | SLDB | 2.16M | $21.58M |
 Sanofi | SNY | 2M | $85.32M |
 Neurocrine Biosciences, Inc. | NBIX | 1.88M | $316.85M |
 Immunocore Holdings plc | IMCR | 1.8M | $57.15M |
 Beta Bionics, Inc. | BBNX | 1.6M | $25.07M |
 Arrowhead Pharmaceuticals, Inc. | ARWR | 1.57M | $128.38M |
 Disc Medicine, Inc. | IRON | 1.55M | $113.37M |
 Zimmer Biomet Holdings, Inc. | ZBH | 1.4M | $120.53M |
 Abbott Laboratories | ABT | 1.4M | $127.04M |
 Tarsus Pharmaceuticals, Inc. | TARS | 1.05M | $66.09M |